The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Lymphotropic herpesviruses in allogeneic bone marrow transplantation
Abstract
Human herpesvirus-6 (HHV-6), human herpesvirus-7 (HHV-7), Epstein-Barr virus (EBV), and human cytomegalovirus (CMV) DNA were repeatedly assayed in peripheral blood leukocytes from 37 allogeneic bone marrow transplant (BMT) patients by polymerase chain reaction. Before BMT, HHV-6 DNA was detected in 8 (22%) patients. HHV-7, EBV, and CMV DNA were detected in 21 (57%), 10 (27%), and 1 (3%) patient, respectively. After BMT, HHV-6 DNA was detected in 26 (70%), HHV-7 in 21 (57%), EBV in 28 (76%), and CMV in 21 (57%) patients. Thirty-two (87%) patients were positive with more than one virus. HHV-6, HHV-7, and EBV DNA were found earlier than CMV DNA in most patients after BMT. The proportions of HHV-6-positive samples during the first 3 months after BMT were higher in the patients with either delayed granulocyte engraftment (P = .04, Fisher's exact test) or delayed platelet engraftment (P = .001, Fisher's exact test). The HHV-6 DNA in samples from the patients with delayed engraftment was confirmed to be variant B. The detection of any lymphotropic herpesvirus was not related to the development of acute graft-versus-host disease (aGVHD). High-dose acyclovir (ACV) prophylaxis significantly (P < .01) reduced the proportion of HHV-6-positive samples and tended to lower HHV-6 DNA levels (P = .06). Our data indicate that HHV-6 variant B can inhibit marrow engraftment and that high-dose ACV may be beneficial to engraftment after BMT by preventing HHV-6 reactivation. No relation between the proportions of HHV-7-, EBV-, and CMV-positive samples in the first 3 months and engraftment or aGVHD was found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Latent human herpesvirus 6 infection of human monocytes/macrophages
Kondo, K., Kondo, T., Okuno, T., Takahashi, M., & Yamanishi, K. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-6-1401 · Cited by 341
Cited by
Emery, V. C., Sabin, C. A., Cope, A. V., Gor, D., Hassan-Walker, A. F., & Griffiths, P. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02350-3 · Cited by 545
Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy
De Bolle, L., Naesens, L., & De Clercq, E. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.217-245.2005 · Cited by 529
Braun, D. K., Dominguez, G., & Pellett, P. E. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.521 · Cited by 492
Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Zerr, D. M., Corey, L., Kim, H. W., Huang, M., Nguy, L., & Boeckh, M. (2005) · Clinical Infectious Diseases · doi:10.1086/428060 · Cited by 338
Ljungman, P., de la Camara, R., Cordonnier, C., Einsele, H., Engelhard, D., Reusser, P., Styczynski, J., Ward, K., & Leukemia, F. T. E. C. O. I. I. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.162 · Cited by 291
Self-citation
Metadata
- Authors
- Wang, F., Dahl, H., Linde, A., Brytting, M., Ehrnst, A., & Ljungman, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1996-11-01
- Volume
- 88
- Issue
- 9
- Pages
- 3615-3620
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2412390281
- Cited by
- 184
- References
- 1
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lymphotropic herpesviruses in allogeneic bone marrow transplantation. https://app.cochat.ai/papers/10.1182/blood.v88.9.3615.bloodjournal8893615
- The paper
- Wang, F., Dahl, H., Linde, A., Brytting, M., Ehrnst, A., & Ljungman, P. (1996). Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood. https://doi.org/10.1182/blood.v88.9.3615.bloodjournal8893615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.